During the Period 2017-2021, Global Epinephrine Autoinjector Market to Grow at a CAGR of 14.58%
ResearchMoz presents professional and in-depth study of "Global Epinephrine Autoinjector Market 2017-2021". Epinephrine is among the first line of treatment drugs for anaphylactic conditions and is considered a life-saving drug during emergencies. Epinephrine autoinjectors have proved to be a life savior for people with severe allergies from as early as the 1980s. The global epinephrine autoinjector market has been witnessing continuous technological innovations and developments over the years, after the first FDA approval of EpiPen in 1987. Technavios analysts forecast the global epinephrine autoinjector market to grow at a CAGR of 14.58% during the period 2017-2021. Covered in this report The report covers the present scenario and the growth prospects of the global epinephrine autoinjector market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of various epinephrine autoinjectors to key end-users such as hospitals, cl...